Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Johnson and Johnson...

    Johnson and Johnson defends itself in trial over baby powder asbestos claims

    Written by Ruby Khatun Khatun Published On 2018-05-16T09:30:18+05:30  |  Updated On 16 May 2018 9:30 AM IST
    Johnson and Johnson defends itself in trial over baby powder asbestos claims

    A trial for a lawsuit alleging that Johnson and Johnson Baby Powder was responsible for the death of a woman due to her exposure to cancer-causing asbestos began in South Carolina on Monday in the latest case against the healthcare conglomerate and a supplier over their talc-based products.


    J&J said that its widely-used baby powder never contained asbestos, a known carcinogen linked to mesothelioma.


    The case also names as a defendant a local unit of Rite Aid, one of the largest U.S. drugstore chains, which allegedly sold the baby powder used by the woman.


    The case marked the first time a drugstore was involved in a talcum powder liability trial and a lawyer for the company, Sarah Johnston, said there was no reason for Rite Aid to be part of the suit.


    In opening statements, a lawyer for the family of Bertila Boyd-Bostic, who died of a rare form of cancer in 2017 at the age of 30, told a jury in the Darlington County Court of Common Pleas that J&J had known for decades that its baby powder contained asbestos.


    J&J and its supplier, a unit of Imerys SA, deny the allegations, and their lawyers said their talc product did not cause any form of cancer, according to an online broadcast of the trial by Courtroom View Network.


    The case is one of several in recent months that alleged asbestos in talc products caused mesothelioma.





    A New Jersey state court jury in April ordered J&J and Imerys to pay $117 million to a man who alleged he developed mesothelioma due to asbestos exposure from J&J Baby Powder. An appeal is pending.



    J&J has also been battling some 6,000 cases claiming its baby powder caused ovarian cancer.


    Boyd-Bostic used baby powder nearly all her life, her family’s lawyer, Christopher Swett, said on Monday. In 2016, she was diagnosed with pericardial mesothelioma, an extremely rare form of cancer that develops in the lining around the heart.


    “J&J’s choices are why we’re here,” Swett said. He accused the company of concealing knowledge of asbestos contamination since the 1970s and choosing not to warn consumers of the risks.


    Bruce Bishop, a lawyer for J&J, said there was no evidence in Boyd-Bostic’s medical records that her mesothelioma was in any way related to asbestos exposure.




    Michael Brown, another J&J lawyer, said millions of people had used Johnson & Johnson Baby Powder without developing any diseases. “And that’s because it does not contain asbestos,” he said.





    (Reporting by Tina Bellon)


    asbestosbaby powdercarcinogenJohnsonJohnson and Johnsonlawsuitmesothelioma
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok